Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies
- 29 May 2003
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 52 (2) , 131-138
- https://doi.org/10.1007/s00280-003-0636-6
Abstract
To investigate the cytotoxic and antitumor effects of the combination of the novel anticancer drug ET-743 and doxorubicin (Dx) and to determine whether any pharmacokinetic interaction occurs in sarcoma-bearing mice.Keywords
This publication has 0 references indexed in Scilit: